Patents by Inventor Stephen M. Condon

Stephen M. Condon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IAP BINDING COMPOUNDS
    Publication number: 20090048183
    Abstract: IAP binding molecules and compositions including these are disclosed. The IAP binding molecules interact with IAPs (inhibitor of apoptosis proteins) in cells and may be used to modify apoptosis in cells treated with such molecules. Embodiments of these compounds have a Kd of less that 0.1 micromolar. Methods of using these IAP binding molecules for therapeutic, diagnostic, and assay purposes are also disclosed.
    Type: Application
    Filed: October 9, 2008
    Publication date: February 19, 2009
    Applicant: TETRALOGIC PHARMACEUTICALS CORPORATION
    Inventors: Stephen M. Condon, Matthew G. LaPorte, Yijun Deng, Susan R. Rippin
  • IAP binding compounds
    Patent number: 7456209
    Abstract: IAP binding molecules and compositions including these are disclosed. The IAP binding molecules interact with IAPs (inhibitor of apoptosis proteins) in cells and may be used to modify apoptosis in cells treated with such molecules. Embodiments of these compounds have a Kd of less that 0.1 micromolar. Methods of using these IAP binding molecules for therapeutic, diagnostic, and assay purposes are also disclosed.
    Type: Grant
    Filed: July 15, 2005
    Date of Patent: November 25, 2008
    Assignee: Tetralogic Pharmaceuticals Corporation
    Inventors: Stephen M. Condon, Matthew G. LaPorte, Yijun Deng, Susan R. Rippin
  • Method for the use of pyranoindole derivatives to treat infection with Hepatitis C virus
    Patent number: 7217730
    Abstract: The invention is directed to methods of treating, preventing, or inhibiting a Hepatitis C viral infection in a mammal comprising contacting the mammal with an effective amount of a compound of the formula: Wherein substitutions at R1, R2, R3—R12, and Y are set forth in the specification.
    Type: Grant
    Filed: May 20, 2003
    Date of Patent: May 15, 2007
    Assignees: Wyeth, ViroPharma Incorporated
    Inventors: Ariamala Gopalsamy, John W. Ellingboe, Tarek S. Mansour, Stephen M. Condon, Matthew G. Laporte, Christopher J. Burns, Kaapjoo Park, Marc S. Collett
  • Substituted oxoazaheterocyclyl compounds
    Publication number: 20040102450
    Abstract: This invention is directed to oxoazaheterocycyl compounds which inhibit Factor Xa, to oxoazaheterocycyl compounds which inhibit both Factor Xa and Factor IIa, to pharmaceutical compositions comprising these compounds, to intermediates useful for preparing these compounds, to a method of directly inhibiting Factor Xa and to a method of simultaneously directly inhibiting Factor Xa and Factor IIa..
    Type: Application
    Filed: July 25, 2003
    Publication date: May 27, 2004
    Applicant: AVENTIS PHARMACEUTICALS INC.
    Inventors: William R. Ewing, Michael R. Becker, Yong Mi Choi-Sledeski, Heinz W. Pauls, Wei He, Stephen M. Condon, Roderick S. Davis, Barbara A. Hanney, Alfred P. Spada, Christopher J. Burns, John Z. Jiang, Aiwen Li, Michael R. Myers, Wan F. Lau, Gregory B. Poli, Mark A. Bobko, Robert L. Morris, Joseph M. Karpinski, Timothy F. Gallagher, Kent W. Neuenschwander, Robert D. Groneberg, Jean-Francois Sabuco
  • Method for the use of pyranoindole derivatives to treat infection with Hepatitis C virus
    Publication number: 20040082643
    Abstract: The invention is directed to methods of treating, preventing, or inhibiting a Hepatitis C viral infection in a mammal comprising contacting the mammal with an effective amount of a compound of the formula: 1
    Type: Application
    Filed: May 20, 2003
    Publication date: April 29, 2004
    Applicants: Wyeth, ViroPharma Incorporated
    Inventors: Ariamala Gopalsamy, John W. Ellingboe, Tarek S. Mansour, Stephen M. Condon, Matthew G. Laporte, Christopher J. Burns, Kaapjoo Park, Marc S. Collett
  • Peptide parathyroid hormone analogs
    Patent number: 6472505
    Abstract: This invention is directed to cyclic and acyclic analogs of hPTH(1-34) and hPTHrP(1-34), to pharmaceutical compositions comprising these peptide compounds, and to a method of treating diseases associated with calcium regulation in the body.
    Type: Grant
    Filed: January 12, 1999
    Date of Patent: October 29, 2002
    Assignee: Aventis Pharmaceuticals Inc.
    Inventors: Stephen M. Condon, Isabelle Morize
  • Peptide parathyroid hormone analogs
    Publication number: 20020132973
    Abstract: This invention is directed to cyclic analogs of hPTH(1-34) and hPTHrP(1-34), to pharmaceutical compositions comprising these peptide compounds, and to a method of treating diseases associated with calcium regulation in the body.
    Type: Application
    Filed: March 13, 2002
    Publication date: September 19, 2002
    Inventors: Stephen M. Condon, Isabelle Morize
  • Processes and intermediates for preparing macrocycles
    Patent number: 5621108
    Abstract: Novel processes for the preparation of lactam- and lactone-containing macrocyles are provided. In preferred embodiments, rapamycin and demethoxyrapamycin are prepared by a convergent synthesis regime. Intermediates useful in the synthetic processes are also provided.
    Type: Grant
    Filed: December 5, 1994
    Date of Patent: April 15, 1997
    Assignee: Trustees of the University of Pennsylvania
    Inventors: Amos B. Smith, III, Stephen M. Condon, Johnnie L. Leazer, Jr., Robert E. Maleczka, John A. McCauley, James W. Leahy